TNFa mRNA and protein biosynthesis were examined in the adult feline heart after stimulation with endotoxin. When freshly isolated hearts were stimulated with endotoxin in vitro, de novo TNFa mRNA expression occurred within 30 min, and TNFa protein production was detected within 60-75 min; however, TNFa mRNA and protein production were not detected in diluent-treated hearts. Immunohistochemical studies localized TNFa to endothelial cells, smooth muscle cells, and cardiac myocytes in the endotoxin-treated hearts, whereas TNFa immunostaining was absent in the diluent-treated hearts. To determine whether the cardiac myocyte was a source for TNFa production, two studies were performed. First, in situ hybridization studies, using highly specific biotinylated probes, demonstrated TNFa mRNA in cardiac myocytes from endotoxin-stimulated hearts; in contrast, TNFa mRNA was not expressed in myocytes from diluent-treated hearts. Second, TNFa protein production was observed when cultured cardiac myocytes were stimulated with endotoxin, whereas TNFa protein production was not detected in the diluent-treated cells. The functional significance of the intramyocardial production of TNFa was determined by examining cell motion in isolated cardiac myocytes treated with superfusates from endotoxinand diluent-stimulated hearts. These studies showed that cell motion was depressed in myocytes treated with superfusates from the endotoxin-treated hearts, but was normal with the superfusates from the diluent-treated hearts; moreover, the negative inotropic effects of the superfusates from the endotoxin-treated hearts could be abrogated completely by pretreatment with an anti-TNFa antibody. Finally, endotoxin stimulation was also shown to result in the intramyocardial production of TNFa mRNA and protein in vivo.
Introduction
The deleterious effects of bacterial endotoxin in the mammalian host have been recognized for at least 100 yr ( 1) . This statement notwithstanding, our understanding of the complex sequence of events that lead to the development of endotoxin-mediated septic shock is still evolving. Indeed, relatively recent studies have identified a potentially important role for circulating myocardial depressant factors such as TNFa in the pathogenesis of endotoxin-mediated septic shock (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . While the exact nature of the cell types involved in the endotoxin-mediated release of TNFa has never been established conclusively, it has been traditionally held that the activated monocyte/macrophage is the cell type that is primarily responsible (12) . However, several considerations suggest that the release of TNFa by macrophages/monocytes does not satisfactorily explain the development of myocardial depression during septic shock. That is, while the negative inotropic effects of TNFa are concentration dependent (3, 13) , immunologically detectable levels of TNFa in the circulation do not correlate with the degree of hemodynamic compromise during sepsis (14, 15) . Further, although TNFa produces negative inotropic effects in the heart within minutes (3, 13) , the development of endotoxin-induced myocardial depression generally lags several hours behind the temporal appearance of TNFa in the serum and occurs in human subjects at a time when TNFa is no longer immunologically detectable in the serum (7, 16, 17) . Important to the above discussion is the recent observation that endotoxin-induced biosynthesis of TNFa mRNA and protein is not strictly confined to peripheral mononuclear cells but may also occur within a number of different "tissue compartments" (18-23). Indeed, a recent experimental study has shown that endotoxin stimulation leads to de novo expression of TNFa mRNA in the heart (20) . This latter observation raises the interesting possibility that the myocardial depression that occurs in sepsis may develop directly in response to the compartmentalized production of TNFa in the heart, as opposed to the systemic production of TNFa by circulating mononuclear cells. Unfortunately, the aforementioned experimental study (20) did not address the important issue of whether TNFa protein was also produced within the myocardium. Accordingly, the purpose of this study was to systematically examine the biosynthetic and functional effects of endotoxin stimulation in the adult heart. The results of this study constitute the initial demonstration that the adult mammalian myocardium elaborates biologically active TNFa, both in vitro and in vivo. Moreover, this study shows that the adult cardiac myocyte itself may be an important source of TNFa production after stimulation with endotoxin.
Methods

Myocardial TNFa production in vitro
Myocardial TNFa production was assessed in vitro using a modified Langendorff perfusion apparatus (24, 25) . Briefly, adult cats weighing 3.4±0.2 kg, and of random sex, were anesthetized with ketamine hydro-chloride (50 mg/kg intramuscular) and acepromazine maleate (5 mg/ kg intramuscular). Before excising the heart, 20 cm3 of blood was gently withdrawn from the femoral artery and allowed to clot in a polystyrene tube; the serum was rapidly separated from the cells by centrifugation at 1,500 g for 10 min. The serum was then filtered with 0.22-I.m filter to ensure sterility as well as to remove any contaminating cell types. Once the serum was obtained, the hearts were excised rapidly, rinsed thoroughly in chilled (40C) Krebs-Henseleit buffer (KHB), suspended on a cannula, and then perfused at a constant pressure of 80 mmHg using a roller pump. The initial coronary superfusate consisted of a nonrecirculating KHB 02 and maintained at 370C by a water bath. The heart was initially perfused for 10 min with KHB buffer in a nonrecirculating fashion to remove any blood products; next the superfusate was changed to a recirculating KHB buffer (total volume 300 ml) containing 5% autologous feline serum (26) supplemented either with endotoxin (10 or 125 jig/ml) or diluent (KHB buffer).
Starting immediately after switching to the recirculating KHB buffer (time 0) and for every 15 min thereafter for a total of 180 min, a 5-ml sample of the recirculating KHB buffer was collected to determine TNFa bioactivity, as assessed by L929 cytotoxicity assay.
Myocardial 7NFa gene expression in vitro
To study myocardial TNFa gene expression, perfused hearts were stimulated as described previously, either with diluent or a single concentration of endotoxin (125 Ag/ml). To determine the time course of TNFa gene expression after diluent or endotoxin stimulation, starting at time 0 and for every 30 min thereafter for a total of 90 min, a 1-2-gram sample of myocardium was excised from the suspended heart (carefully sparing the large epicardial vessels). The sample was then frozen rapidly in liquid nitrogen and stored at -70°C. To study the kinetics of TNFa gene expression after removal of endotoxin stimulation, the hearts were first perfused for 90 min with a KHB buffer containing 125 ,ug/ml endotoxin. After this, the superfusate was switched to a solution consisting of KHB buffer alone, and the hearts were perfused for an additional 120 min (total perfusion time 210 min). A 1-2-gram sample of myocardium was excised from the suspended heart at 90, 150, 180, and 210 min, frozen rapidly in liquid nitrogen, and stored at -70°C. The positive controls for these experiments consisted of HL-60 cells stimulated for 180 min with endotoxin (125 jig/ml).
Total RNA was extracted from the myocardial samples and the HL-60 cells by the guanidinium thiocyanate method (27). Total RNA was denatured at 65°C for 10 min, size fractionated on a 1% agarose gel containing 2.2 M formaldehyde ( 10 Hg/ lane), transferred onto a nylon membrane (GeneScreen; Dupont-NEN, Boston, MA), and hybridized sequentially to random primed cDNA probes (27). The following probes were used for Northern blot analysis: a 0.6-kb HindHI/ HindIl fragment of the human TNFa (American Tissue Culture Collection, Rockville, MD) and a 0.5-kb Xba/ HindE fragment of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which was used as an internal control. In preliminary control experiments we confirmed that the human TNFa cDNA probe crossreacted with feline TNFa mRNA by hybridizing the cDNA probe to mRNA isolated from endotoxinstimulated (10 Isg/ml x 180 min) feline and human mononuclear cells.
The membranes were washed one time with SSC and 0.1% SDS at 55°C for 30 min, air dried, and exposed to Kodak X-Omat A film (Eastman Kodak, Rochester, NY) at -70°C.
Immunolocalization of myocardial TNFa
To visualize the presence and anatomic localization of TNFa within the myocardium, immunohistochemical studies were performed. Freshly excised hearts were stimulated with diluent or endotoxin (125 Ag/ml) for 180 minutes and fixed in 10% neutral buffered formalin (Z-fix; Anatech, Ltd., Battle Creek, MI) at room temperature for 18-24 h. The tissue was then dehydrated, embedded in paraffin, and sectioned (0.5-jiM sections) in a standard manner. Immunohistochemistry was performed using a computer-driven CODE-ON system (Cambridge Instruments, Nubloch, Germany). All reagents were prepared with a diluent consisting of PBS supplemented with 0.2% Tween 20 and 0.5% BSA. To minimize background staining, all sections were first blocked with normal goat serum for 20 min at room temperature. Next, the slides were incubated with two concentrations ( 1:500 or 1:1,000) of a primary antibody directed against human TNFa (Genzyme Corp., Cambridge, MA); control slides were stained with secondary antibody alone (1 / 1,000 dilution). Sections were allowed to incubate in a humidified chamber overnight at room temperature. The slides were then rinsed in PBS and incubated for 45 min at room temperature with a biotin-conjugated goat anti-rabbit secondary antibody (diluted 1/1,000). After blocking of the endogenous peroxidase activity with methanol and hydrogen peroxide, the slides were incubated with an avidin-biotin complex using a peroxidase reporter (Vectastain ABC Kit; Vector Laboratories, Burlingame, CA). Diaminobenzidine was used as the chromogen to visualize the presence and distribution of TNFa. Sections were then rinsed in PBS, counterstained in hematoxylin, dehydrated, cleared, and mounted using a synthetic mounting medium.
Cellular source for myocardial TNFa production in vitro
Previous studies have shown that a variety of cell types in the heart, including fibroblasts, smooth muscle cells, and endothelial cells, elaborate TNFa (23, 28, 29) . To determine whether the cardiac myocyte might also elaborate TNFa, three separate experiments were performed.
First, to study the relative production of TNFa mRNA and protein by myocyte and nonmyocyte cell types in the heart, freshly isolated cat hearts were stimulated with endotoxin (125 Mg/ml) for 120 min, as described earlier. The hearts were then enzymatically digested using techniques standard in this laboratory (24, 30) . After enzymatic digestion of the heart, the cells were rinsed with KHB and gently centrifuged (200 g) to separate the myocyte from nonmyocyte cell types. The resultant cell pellet, which contains > 95% cardiac myocytes, and the cell supernatant, which contains > 95% nonmyocyte cell types, were then split into two portions and analyzed for TNFa mRNA and protein production. Total RNA was extracted and prepared for Northern analysis as described earlier, using random primed cDNA probes for TNFa and GAPDH. Cytosolic TNFa protein was prepared using a modification of the method of Pizarro et al. (31 ) . Briefly, the cell pellet and supernatant were each subjected to two rapid freeze-thaw cycles, by rapidly immersing the cells in liquid nitrogen and warming the cells in a 37°C water bath. The cells were then suspended in PBS and sonicated for 60 s. The lysed cells were then spun down at 5,000 g to remove particulate cell debris, and the resultant supernatants (cytosolic fraction) from the myocytes and nonmyocytes were tested for TNFa cytotoxicity, using an L929 bioassay as described later. In previous studies we have shown that all of the immunodetectable TNFa in myocardium (human) resides in the cytosolic fraction of myocardial homogenates (32) . The amount of TNFa per sample was normalized by the total amount of cytosolic protein. Protein determinations were performed using a commercially available assay (BCA; Pierce, Rockford, IL), using BSA as a standard.
Second, to determine the cellular source(s) of TNFa mRNA production, we performed in situ hybridization studies in diluent-and endotoxin-stimulated hearts. In situ hybridization was performed using custom-synthesized biotinylated oligonucleotide probes (33) . A specific antisense oligonucleotide probe was designed based on a segment contained in the coding region of the TNFa gene that was unique to the cat and has not been reported in other vertebrate sequences recorded in GenBank (Intelligenetics, Inc., Mountainview, CA). The antisense oligonucleotide was derived from bases 825-847 of the coding region of TNFa, whose sequence was 5' CGGGGTTTGCTACTACATGGGC 3'. To check for the specificity of the hybridization signal, a biotinlabeled sense probe (sequence 5' GCCCATGTAGTAGCAAACCCCG 3') corresponding to the antisense probe was substituted. Further, to confirm the integrity of the mRNA in each sample, a biotinylated d(T)24 single-stranded oligonucleotide was used in all diluent-and endotoxintreated myocardial samples (33) . All oligonucleotide probes were hyTumor Necrosis Factor and Myocytes perbiotinylated at the 3' end (i.e., three biotin groups attached at the 3' end) and were synthesized commercially (DNAgency, Ashton, PA).
In situ hybridization was performed exactly according to the method of Bucana et al. (33) . Briefly, frozen tissue from diluent and endotoxin hearts were embedded in OCT compound (Miles Laboratories, Elkhart, IN), cut into 5.0-pim sections, and placed on positively charged glass microscope slides (ProbeOn' Plus; Fisher Scientific, Pittsburgh, PA).
The tissue sections were allowed to come to room temperature, fixed for 20 min in 4% paraformaldehyde, and then mounted on a Microprobe. (Fisher Scientific) slide holder. Tissue sections were treated with 1% Triton X-100 in diethyl pyrocarbonate (DEPC) -treated distilled water for 5 min, followed by protein denaturation with 0.2 N HCl in DEPC water at 990C for 3 min. In situ hybridization was performed using a probe cocktail consisting of 1:50,000 dilution of random sequence oligomers (9 bases long), which were added to aid nucleic acid denaturation (34) , and a 1:500 or 1:1,000 dilution of the antisense, sense, or poly d(T) oligonucleotide probes. First, the probe cocktail was heated for 3 min at 990C to denature the oligonucleotides. Hybridization of the probes to the tissue samples was performed at 450C for 45 min and the slides washed for 3 min with 2 x SSC three times at 450C. The hybridized biotinylated probes were localized colorimetrically by incubating the slides with avidin-conjugated alkaline phosphatase, followed by nap Third, to determine whether endotoxin stimulation would be a sufficient stimulus for TNFa production in cultured adult cardiac myocytes, we treated freshly isolated adult feline cardiac myocytes with diluent or endotoxin. Briefly, cardiac myocytes were isolated from normal cat hearts using standard enzymatic and cell culture techniques (24, 30) . We have shown previously that fibroblast contamination is minimal (< 2%), using the cell culture methods described herein (24) . The freshly isolated myocytes were suspended in M199 culture medium at a final concentration of 5 x 104 cells/ml and allowed to equilibrate for 1 h. The myocyte cultures were stimulated for 4 h either with diluent (M 199) or with endotoxin (10 jsg/ml). The cells were then centrifuged at 1,500 g for 10 min and the cell pellets frozen immediately in liquid nitrogen. The cytosolic portions of the diluent-and endotoxin-stimulated cells were prepared exactly as described earlier (31) . The amount of TNFa per myocyte culture was normalized by the total amount of cytosolic protein per culture; protein determinations were performed using a commercially available assay (BCA; Pierce), using BSA as a standard.
Three control studies were performed to determine the extent to which contaminating monocytes may have contributed to TNFa production in the myocyte cultures. First, we used flow cytometry to determine the number of monocytes present in the freshly isolated myocyte cultures. Briefly, myocyte cultures were prepared as described earlier and then immunostained for 30 min at 4°C with saturating quantities of phycoerythrin-conjugated murine anti-CD14 (Dako Corp., Carpinteria, CA) or phycoerythrin-conjugated murine IgG, isotype control sera. The cultures were then washed with cold Dulbecco's phosphate-buffered saline and fixed in 1% paraformaldehyde. Flow cytometry (Epics Profile I; Coulter Cytometry, Hialeah, FL) was performed using an argon beam laser tuned to 488 nm, with three fluorescence channels. Fluorescence data from isotype controls were subtracted from data obtained with the anti-CD14 antibodies. The percentage of contaminating monocytes was also determined in a different manner, by incubating the myocyte cultures with fluorescent beads (Molecular Probes, Eugene, OR) and then using microspectrofluorometry to determine the number of cells phagocytosing the fluorescent beads. In preliminary control experiments, we confirmed that the cardiac myocytes did not phagocytose the fluorescent beads. Second, we determined the amount of TNFa production that was theoretically possible based on the predicted number of contaminating monocytes in the myocyte cultures. For these studies, feline peripheral blood mononuclear leukocytes were harvested using gradient centrifugation (Ficoll,) and lymphocyte separation medium (Organon Teknika, Durham, NC), enumerated using a hemocytometer, and then cultured in RPMI medium containing 10% FCS. The fraction of monocytes in the peripheral blood mononuclear cell cultures was calculated from the percentage of mononuclear cells phagocytosing iron beads, which was also the same as the percentage of mononuclear cells that stained positively for CD14. The number of peripheral blood mononuclear cells per culture dish was adjusted such that the absolute number of monocytes in culture bracketed the absolute number of monocytes present in the myocyte cultures. The peripheral blood mononuclear cells were stimulated with endotoxin exactly as described earlier for the cardiac myocytes, and the amount of mononuclear cell-derived TNFa (U/ml) was measured by bioassay. Finally, we examined TNFa production in monocyte-depleted myocyte cultures in the presence and absence of endotoxin stimulation. For these studies, monocyte depletion was achieved by incubating the myocyte cultures with iron beads (Technicon Instrument Co., Tarrytown, NY) for 1 h at 370C in RPMI medium containing 10% autologous cat serum. The monocytes, which will phagocytize the iron beads, were then selectively depleted from the myocyte cultures using a magnet (Dynal, Great Neck, NY). In preliminary control experiments we determined that, under the culture conditions used herein, viable cardiac myocytes did not ingest iron beads. The amount of TNFa in the monocyte-depleted myocyte cultures was determined as described earlier.
Myocardial TNFa mRNA and protein biosynthesis in vivo
To determine whether endotoxin challenge would stimulate TNFa mRNA and protein production in vivo, adult cats of random sex, weighing 3.4±0.2 kg, were anesthetized, instrumented with a 20-gauge cannula, and treated with either diluent or endotoxin. Endotoxin was administered as an initial 100 ,ug/kg bolus intravenously over 5 min (35), followed by five subsequent 100 jig/kg boluses every 15 min, beginning 60 min after the initial administration of endotoxin. Diluent was administered in an analogous fashion. The animals were observed for 3 h and were then killed under deep anesthesia. At the time of killing (180 min), the liver, spleen, and heart were removed, washed three times in chilled PBS (4°C), and frozen in liquid nitrogen. Total RNA and cytosolic proteins were prepared as described earlier.
Detection of TNFa mRNA in the liver, spleen, and heart from diluent-and endotoxin-treated animals was performed using PCR amplification, according to the methods described by Ma et al (36) . The oligonucleotide primers were chosen based on unique cDNA sequences published for feline TNFa (GenBank sequence FDTNFA). The sense (S) primer (5'-CTTCTCGAACTCCGAGTGACAAGCC-3') was derived from bases 239-254 of the coding region of TNFa; the antisense primer (AS) used (5'-TGATGGCGTGGGTGAGGAGCACATG-'3) was derived from bases 445-470 of the coding region of TNFa. PCR amplification of total mRNA from spleen, liver, and heart was performed by denaturing the samples at 80°C for 5 min in a volume of 10 j1 containing lx reverse transcriptase (RT)' buffer (GIBCO BRL, Gaithersburg, MD), 1.0 ,uM AS primer, and 1.0 mM dNTP. RT was initiated by the addition of 5 ILI of RT mix: 1.5 /4 RT (10 U./ /4; Promega Corp., Madison, WI), 1.5 y1 RNAsin (40 U/,ul; Promega), 1.5 j1i 0.1 M DTT, 0.5 /4 10 x RT buffer at 37°C for 60 min. To control for the possibility that the resulting PCR product was secondary to DNA contamination, the mRNA samples from spleen, liver, and heart were incubated in the above reaction mixture without added RT.
PCR amplification was performed by adding 16 jil of a PCR mix to 4 ,ul of cDNA product, which resulted in 1 X PCR buffer, 0.2 mM dNTP, 0.2 jiM of primer pairs, 2.0 mM MgSO4, and 0.05 U/til of Taq polymerase. The parameters for PCR amplification were exactly as described previously (36) and were carried out for 30 cycles. The PCR reaction products were separated on 1.5% agarose gel, stained with ethidium bromide, and visualized by ultraviolet light.
TNFa proteins in the spleen, liver, and hearts of diluent-and endotoxin-treated animals were assayed using a modification of the method 1. Abbreviation used in this paper: RT, reverse transcription. (MT) assay, as described (37) . All values were reported as the mean of triplicate measurements. The specificity of all TNFa-induced effects was determined by neutralization of serum/cytosolic cytotoxicity with an anti-TNFa antibody (Genzyme Corp.) (37) . In preliminary control experiments, we determined that the lower limit of sensitivity for this technique was in the range of 2-4 U/ml of TNFa and that each interand intra-assay coefficient of variation for this bioassay was < 5.0%; these values are similar to those we reported for 1591-RE 3.5 cells (37) .
TNFa-induced negative inotropic effects. The presence or absence of TNFa in the superfusates of the diluent-and endotoxin-treated hearts was also assessed using a simple cell motion assay, exactly as described previously (13, 37) . Briefly, adult feline cardiac myocytes were freshly isolated (24, 25, 30) , allowed to stabilize for 1 h, and then treated for 30 min at 370C with a 1:5 or 1:10 dilution of superfusate from either diluent-or endotoxin-treated hearts. The appropriate controls for these studies consisted of myocytes treated with diluent alone (1% HSA) or 200 U/mI recombinant human TNFa (rhTNFa) (Genzyme Corp.). To confirm the specificity of any superfusate-induced effects on cell motion, the 1:5 dilution of the superfusate from the endotoxin-treated heart was preincubated for 60 min with 1.0 Al/ml of a neutralizing polyclonal rabbit anti-human TNFa, as we described previously (13) . Cell motion was characterized by video-edge detection, at a stimulation frequency of 0.25 Hz, using experimental conditions identical to those we described elsewhere (13, 37) . For these studies, we examined the percentage of change in cell length. To compare results between different myocyte isolations, the values for cell shortening were expressed as a fold-change in the amplitude of cell shortening compared with control values from that same myocyte isolation. Thus, for each of the dose-response studies described earlier, there was always an appropriate control group that was obtained from the same primary myocyte isolation.
Statistics
Each value is expressed as a mean±SE. Nonpaired Student's t test was used to examine TNFa levels in diluent and endotoxin treated hearts in vitro and in vivo. One-way analysis of variance was used to test for mean differences in cell shortening after treatment with rhTNFa or to test for superfusates from the endotoxin-or diluent-treated hearts; where appropriate, post-hoc multiple comparison testing (Dunnett's test) was performed to test for differences between control and experimental groups. Significant differences were said to exist at P < 0.05.
Results
Myocardial TNFa protein production in vitro. Fig. 1 illustrates the time course for the appearance of TNFa bioactivity in the superfusate from a typical freshly isolated, buffer-perfused heart stimulated with endotoxin ( 125 ug/ml). As shown, TNFa bioactivity was not detectable in the myocardial superfusate under baseline conditions; however, TNFa bioactivity was detectable in the superfusate 90 min after endotoxin administration and continued to increase throughout the course of endotoxin stimulation (total 180 min). TNFa bioactivity in the superfusate from (37) . The inset shown in Fig. 1 depicts group data for feline hearts perfused (180 min) with diluent (n = 5), 10 j.g/ml endotoxin (n = 5), or 125 jtg/ml endotoxin (n = 3). The salient finding
shown by this inset is that, whereas TNFa bioactivity was not detected in any of the diluent-treated hearts, TNFa bioactivity was significantly increased in the superfusates from the hearts stimulated with either 10 or 125 jig/ml of endotoxin (P < 0.01 and < 0.001, respectively, compared with control values). The specificity of the TNFa-induced cytotoxic effects was confirmed using an anti-TNFa antibody, which neutralized the cytotoxicity in the superfusates obtained with either 10 or 125 jig/ml of endotoxin.
Myocardial TNFa mRNA production in vitro. Fig. 2 A shows that TNFa mRNA was not detectable by Northern blot analysis at baseline or any of the other time points examined in the heart stimulated with diluent alone. In striking contrast, Fig. 2 dotoxin for 210 min, TNFa mRNA levels were constant (data not shown). Similar qualitative findings with respect to TNFa mRNA expression after the removal of endotoxin were observed in two additional hearts.
Intramyocardial immunolocalization of TNFa. Fig. 3 summarizes the results of the immunohistochemical studies conducted to visualize the presence and anatomic localization of TNFa within the myocardium. Fig. 3 A shows that TNFa immunostaining was not detected in the hearts perfused with diluent alone. In striking contrast to the findings in diluent-stimulated hearts, Fig. 3 , C and D, demonstrates that there was obvious TNFa immunostaining in the endotoxin-stimulated hearts. TNFa immunostaining was localized to a variety of cell types, including endothelial cells and smooth muscle cells in the blood vessels and, perhaps most surprising, to the cardiac myocytes themselves. Fig. 3 B shows that there was no nonspecific myocardial immunostaining for TNFa when endotoxin-stimulated hearts were incubated with secondary antibody alone. Similar qualitative findings were observed with additional endotoxin (n = 2) and diluent (n = 2) stimulated hearts.
Cellular source for myocardial TNFa production. The presence of TNFa immunostaining on the cardiac myocytes suggested one of two possibilities: TNFa produced by nonmyocytes became bound to, and therefore immunolocalized to, TNF receptors on the cardiac myocytes (32); alternatively, precursor TNFa (26-kD) was synthesized by the cardiac myocyte and bound to the sarcolemma (38) . To explore the latter possibility, we performed a series of three interrelated experiments to determine whether the cardiac myocyte might be a source for TNFa production. Fig. 4 compares and contrasts the relative production of TNFa mRNA and protein by cardiac myocytes and nonmyocyte cell types in the heart after endotoxin stimulation (n = 3). As shown in the top of Fig. 4 , the supernatants from the cell isolation predominately composed of nonmyocyte cell types (> 95%) expressed both TNFa mRNA and protein. The bottom of Fig. 4 shows that the cell pellets predominantly composed of cardiac myocytes (> 95%) expressed both TNFa mRNA and protein, although the relative amount of TNFa mRNA in the cell pellet appeared less when compared with that observed in the cell supernatants.
To define more definitively the presence of TNFa mRNA in cardiac myocytes, we performed in situ hybridization studies in diluent-and endotoxin-stimulated hearts. Fig. 5, A and B, which serves as the appropriate positive control for the in situ hybridization studies, shows that there was obvious cytoplasmic and nuclear labeling of the cardiac myocytes in the diluent (A) and endotoxin-(B) stimulated hearts when poly T oligonucleotide probes were used. Fig. 5 , C and D, shows that when the diluent-and endotoxin-stimulated hearts were hybridized with the antisense TNFa oligonucleotide probe, there was no labeling of the cardiac myocytes in the diluent-treated hearts (C), whereas there was obvious nuclear and cytoplasmic labeling of the cardiac myocytes in the endotoxin-stimulated hearts (D). Finally, as shown in Fig. 5 , E and F, the sense TNFa oligonucleotide probe did not hybridize to any cell types in the diluent-(E) or endotoxin-stimulated hearts (F). Similar qualitative findings were obtained when the antisense and sense probes were used in additional in situ hybridization studies in endotoxin-(n = 2) and diluent-(n = 2) stimulated hearts.
Third, to determine whether endotoxin challenge would directly stimulate the production of TNFa protein in cultured cardiac myocytes, freshly isolated feline myocytes were stimulated with either diluent (n = 6 primary myocyte isolations) or 10 jig/ml endotoxin (n = 6 primary myocyte isolations). This study showed that TNFa bioactivity was at the lower limit of detectability in the diluent-treated cultures (19±19 U TNFa/ gram of cell protein), whereas the level of TNFa bioactivity was significantly higher (P < 0.001) in the endotoxin-treated cultures (998±630 U/ml TNFa/ gram of cell protein).
Three control experiments were performed to determine the degree to which monocyte contamination may Figure 3 . Immunolocalization of myocardial TNFa in vitro. Immunohistochemical studies were performed in freshly excised feline hearts stimulated for 180 min with diluent or endotoxin ( 125 ug/ml), and the hearts were fixed and sectioned using standard methodology. Myocardial samples from diluent-and endotoxin-stimulated hearts were incubated with a primary antibody directed against human TNFa and a biotin conjugated goat antirabbit secondary antibody. All slides were developed using a peroxidase reporter (see text for details) and were counterstained with hematoxylin.
A shows the immunostaining pattern obtained in a diluent-stimulated heart using both primary and secondary antibodies; B shows the immunostaining pattern obtained in an endotoxin-stimulated heart using a secondary antibody alone (negative control); C and D show the immunostaining pattern in a representative endotoxin-stimulated heart using both primary and secondary antibodies. All photographs were obtained at x400.
the quantity of TNFa production in the endotoxin-treated cardiac myocyte cultures depleted of monocytes (776.4±511 U/ gram; n = 4 dishes) was not significantly different (P > 0.05) when compared with myocyte cultures containing 0.4-0.7% contaminating monocytes (853.9±537 U/ gram; n = 4 dishes).
Functional significance of myocardial TNFa production.
WOCYTES NON4IYOCYTES To determine whether the TNFa produced by the endotoxinstimulated hearts was sufficient to modulate contractility of cardiac myocytes, we incubated freshly isolated cardiac myocytes for 30 min with superfusates from diluent-and endotoxintreated hearts. As shown in Fig. 6 , when the isolated cardiac myocytes were incubated with a 1:5 dilution of the superfusate from the diluent-treated hearts, cell motion was not affected. However, when the cells were incubated with a 1:5 dilution of the superfusate from the endotoxin-treated heart (-200 U/ml TNFa), there was an 25% decrease in the extent of cell shortening, similar to the decrease in cell shortening observed when recombinant human TNFa (200 U/ml) was used. Moreover, the negative inotropic effects of the superfusate from the endotoxin-treated hearts could be completely abrogated by pretreatment with a neutralizing polyclonal TNFa antibody. Analysis of variance indicated that the overall differences in cell shortening among groups were significant (P < 0.001); posthoc analysis of variance testing (Dunnett's test) indicated that the decrease in the extent of cell shortening for cells treated with the 1:5 dilution of the superfusate from the endotoxintreated hearts or recombinant human TNFa was significantly different from control (P < 0.05), whereas the extent of cell shortening for the cells treated with superfusate from the diluent-treated hearts or the superfusate pretreated with a neutralizing polyclonal antibody was not significantly different from control (P > 0.05). Figure 5 . In situ hybridization studies in diluentand endotoxin-stimulated hearts. Freshly isolated cat hearts were stimulated with endotoxin (125 ,ug/ml) or diluent for 180 min; then the tissues were fixed and prepared for in situ hybridization using specific biotinylated probes (see Methods for details). All slides were developed using Fast Red chromagen solution. The left-hand column shows the in situ hybridization studies for diluent-treated hearts; the right-hand column shows the results for endotoxin-stimulated hearts. A and B (positive controls) show that when a poly T oligonucleotide probe was used there was obvious cytoplasmic and nuclear labeling of the cardiac myocytes in both the diluent-and endotoxin-stimulated hearts. C and D show that when the diluent-and endotoxin-stimulated hearts were hybridized to the TNFa antisense oligonucleotide there was obvious labeling of the cytoplasm and nucleus of the cardiac myocytes from the endotoxin-stimulated hearts, whereas there was no hybridization signal evident in the nucleus or cytoplasm of the myocytes in the diluent-treated hearts. E and F show that the TNFa sense probe did not hybridize to any cell types in the diluent-or endotoxin-stimulated hearts.
Myocardial TNFa mRNA and protein biosynthesis in vivo. To determine whether the systemic administration of endotoxin in vivo leads to the compartmentalized production of TNFa mRNA and protein production in the heart, as suggested by the in vitro studies, we challenged cats with either endotoxin or diluent. To determine whether compartmentalized production of TNFa was unique to the heart or whether instead TNFa was produced in other organ systems as well, we also examined TNFa mRNA and protein production in the liver and spleen. The top of Fig. 7 depicts the mRNA levels for heart, liver, and spleen in diluent-(A) and endotoxin-(B) treated heart. As shown, TNFa mRNA was barely detectable by PCR in the liver (lane 2) and spleen (lane 3) and was not detectable in the heart (lane 1) after diluent administration. In contrast, TNFa mRNA was easily detectable by PCR in the heart (lane 1), liver (lane 2), and spleen (lane 3) after administration of endotoxin. TNFa PCR product was not detectable in the heart, liver, or spleen of diluent-or endotoxin-stimulated hearts in the absence of RT (lanes 4-6), thereby excluding the presence of DNA contamination. The bottom of Fig. 7 shows that TNFa bioactivity was detectable in the cytosolic fractions obtained from the liver and spleen of animals treated with diluent alone, whereas TNFa was not evident in the heart (A). In contrast, TNFa bioactivity was readily detectable in the cytosolic fractions of the heart, liver, and spleen obtained from endotoxin-stimulated animals (Fig. 7 B) . In each instance, TNFa bioactivity in the cytosolic fractions from the organs obtained from both diluent-and endotoxin-stimulated animals could be completely neutralized by a polyclonal anti-TNFa antibody.
To determine the cellular source(s) of TNFa mRNA production in the earlier in vivo studies, we performed in situ hybridization studies in hearts from the diluent-and endotoxinstimulated cats. Fig. 8, A and B, shows, respectively, that when an antisense TNFa oligonucleotide probe was hybridized to myocardium obtained from diluent-and endotoxin-stimulated animals, the probe did not hybridize to any of the myocardial cells from the animal stimulated with diluent (A), whereas there was obvious cytoplasmic labeling in the cardiac myocytes from the endotoxin-stimulated animal (B). Fig. 8 , C and D, shows, respectively, that the sense TNFa oligonucleotide probe did not hybridize to any cell types in the myocardial samples from the diluent-or endotoxin-stimulated cats.
Discussion
This simple experimental study, in which the effects of endotoxin were systematically studied in the heart in vitro and in vivo, shows that the adult mammalian heart efficiently synthesizes biologically active TNFa. Five distinct but mutually complementary lines of evidence support this statement. First, whereas TNFa bioactivity was not detectable in the myocardial superfusates (Fig. 1, inset) from the freshly isolated bufferperfused hearts stimulated with diluent, there was a striking increase in the elaboration of biologically active TNFa in the superfusates from the endotoxin-stimulated hearts (Fig. 1, and  inset) . TNFa mRNA was not detectable in naive (unstimulated) hearts (Fig.  2 A) , TNFa mRNA was expressed rapidly (30 min) in the myocardium after endotoxin administration (Fig. 2 B) . Although the coordinated expression of TNFa mRNA and protein in the heart argues for a transcriptional control mechanism for cytokine biosynthesis, the presence of an AT-rich region in the 3' untranslated region of the TNFa gene suggests an alternative mechanism. That is, these sequences (TTA1TJFAT; reference 39), which are common in the 3' untranslated regions of a variety of inflammatory cytokines, have been shown to promote mRNA instability (39, 40) . Accordingly, we cannot discount the possibility that TNFa biosynthesis may have occurred, either wholly or in part, as a result of posttranscriptional stabilization of TNFa mRNA levels. Germane to this discussion was the finding that TNFa mRNA levels returned rapidly toward baseline levels once endotoxin was removed from the superfusate (Fig. 2 C) , thus suggesting that TNFa gene expression was tightly regulated in the heart. Third, immunohistochemical staining studies localized TNFa to cardiac myocytes as well as to endothelial cells, smooth muscle cells in the hearts stimulated with endotoxin, whereas TNFa immunostaining was not apparent in the diluent-stimulated hearts (Fig. 3) . Fourth, when isolated cardiac myocytes were exposed to the superfusates (1:5 dilution) from the endotoxin-stimulated hearts, cell motion was depressed to a degree similar to that observed with recombinant human TNFa (Fig. 6) ; superfusates from diluent-treated hearts had no effect on cell motion. Moreover, the negative inotropic effect of the superfusates from the endotoxin-stimulated hearts could be abrogated completely by pretreating the superfusates with a neutralizing anti-TNFa antibody. Finally, to confirm the biological relevance of the in vitro studies presented herein, we also examined the biosynthetic effects of endotoxin in vivo. These latter studies confirmed our in vitro findings in that we again observed de novo expression of intramyocardial TNFa mRNA and protein synthesis in the endotoxin-stimulated animals, whereas intramyocardial TNFa mRNA and protein synthesis were not observed after administration of diluent in vivo (Figs. 7 and 8) . Thus, these studies constitute the initial demonstration that the production of biologically active TNFa is compartmentalized within adult mammalian heart after administration of endotoxin.
A second important finding of this study was the observation that the adult cardiac myocyte synthesizes not only TNFa mRNA but also TNFa protein. Based on our immunohistochemical studies, which clearly localized TNFa to the cardiac myocyte, as well as previous studies that suggested that cultured cells from whole heart homogenates of newborn rat and murine hearts produced TNFa when stimulated with endotoxin (20, 41) , and a recent study that suggested that myocytes isolated from bum-shocked guinea pigs elaborated TNFa (42), we sought to determine whether the adult cardiac myocyte might be a potential source for TNFa production. As shown by the in situ hybridization studies (Figs. 5 and 8 ), when a highly specific oligonucleotide probe for feline TNFa mRNA was used, TNFa mRNA was identified in the cardiac myocytes from the endotoxin-stimulated hearts, whereas TNFa mRNA was not detected in the myocytes from diluent-treated hearts. To determine whether the TNFa mRNA expressed in adult cardiac myocytes was translated into biologically active protein, we Figure 8 . In situ hybridization studies in diluent-and endotoxin-stimulated cats. Cats were lightly sedated and stimulated for 180 min with either diluent or endotoxin (100 Mg/kg). The animals were killed, and the hearts were removed rapidly and prepared for in situ hybridization and immunohistochemical staining. In situ hybridization was performed on hearts obtained from the diluent-and endotoxin-stimulated animals using Fast Red chromagen solution, as described in Methods. A and B show, respectively, that when the hearts obtained from the diluent-and endotoxinstimulated animals were hybridized with the antisense TNFa oligonucleotide probe there was no labeling of the cardiac myocytes in the diluenttreated animal, whereas there was obvious labeling of the cardiac myocytes from the endotoxin-stimulated animal. C and D show, respectively, that the sense TNFa oligonucleotide probe did not hybridize to any cell type in the hearts obtained from the diluent-and endotoxin-stimulated animals. stimulated freshly isolated adult cardiac myocytes with endotoxin. These studies showed that there was a significant increase in TNFa bioactivity in the endotoxin-stimulated myocyte cultures. Nonetheless, since TNFa mRNA levels were higher in the nonmyocyte fractions (Fig. 4) , it should be recognized that the overall physiological significance of TNFa gene and protein expression in the cardiac myocyte is not yet clear.
Three lines of evidence suggest that it is highly unlikely that monocyte contamination was a major source for TNFa production in the endotoxin-stimulated myocyte cultures discussed earlier. First, we routinely use selective adhesion techniques during our myocyte isolations to minimize fibroblast contamination (43) . Thus, our isolation technique would also be expected to deplete monocytes from the myocyte cultures insofar as monocytes adhere selectively to a plastic substrate, whereas adult cardiac myocytes do not. Second, myocyte cultures that were selectively depleted of monocytes before endotoxin challenge still produced TNFa; moreover, the quantity of TNFa that was produced was not different from that obtained in nondepleted myocyte cultures. Third, to produce the quantity of TNFa that was detected in our endotoxin-stimulated cardiac myocyte preparations, we had to stimulate cultures of mononuclear cells that contained 50 times more monocytes than the number of monocytes estimated to be contaminating our myocyte cultures.
Compartmentalized production of TNFa. Elevated levels of TNFa after endotoxin administration have been well documented in humans since at least 1988 (12, 44) . Whereas it is generally thought that the major source of TNFa production during endotoxemia is the monocyte/macrophage (12), the exact nature of the cell types involved in this process has never been established conclusively. Germane to this discussion is the recent observation that TNFa mRNA is expressed constitutively in a number of mammalian tissues under normal conditions (45-47) and that levels of TNFa mRNA are regulated differently in various tissue compartments during endotoxemia (18-23). For example, endotoxin challenge produces no change in the constitutive levels of TNFa mRNA in the spleen and small bowel ( 18) but increases TNFa mRNA levels in the liver, lung, pancreas, uterus/ fallopian tubes, thymus, and kidney (18, 20) and induces de novo TNFa mRNA expression in the heart (20) . Further, recent experimental reports have identified positive TNFa immunostaining in the kidney, liver, lung, and heart after endotoxin administration (21-23), suggesting that there was ongoing biosynthesis of TNFa in these tissues. Taken together; these studies suggest that compartmentalized biosynthesis of TNFa within organ systems is part of a global response of the host organism to endotoxin provocation. This statement notwithstanding, the heart appears to be unique among the different tissue types studied thus far in that myocardial TNFa biosynthesis requires de novo gene expression.
Conclusion. This simple experimental study provides compelling evidence for the compartmentalized production of biologically active TNFa within the adult heart after administration of endotoxin. While direct correlations between the experimental effects of endotoxin in the isolated heart and the complex effects of endotoxemia in the heart during systemic sepsis are not appropriate, these data provide several potentially important insights into the pathogenesis of endotoxin-induced septic shock. First, the finding that endotoxin-induced production of TNFa is compartmentalized suggests that the depressed myocardial function that develops during systemic sepsis may be a paracrine, autocrine, or intracrine effect of TNFa, as opposed to a systemic endocrine effect as previously supposed (8, 9) . The significance of this statement is that TNFa produced within the heart and/ or other tissues may not be neutralized by naturally occurring biological buffers such as circulating (shed) soluble TNF receptors (37) , which by virtue of their size, charge, or tertiary structure may not penetrate the interstices of some tissues. Second, the extent of myocardial TNFa production per gram of tissue suggests that the heart, and undoubtedly other tissues as well, may contribute to the total cytokine burden during systemic sepsis. Indeed, the production of TNFa within various tissue compartments may be one of the reasons why circulating TNFa levels do not necessarily predict clinical outcome during systemic sepsis (48) .
While these statements have focused attention on the potential deleterious effects of TNFa in the heart, the data also suggest an alternate hypothesis. That is, the coordinated regulation of myocardial TNFa mRNA and protein synthesis implies that the elaboration of TNFa in the heart is not a random event in nature; this in turn suggests the intriguing possibility that the biosynthesis of TNFa in the heart may confer some as yet unknown survival benefit to the host. While such a broad, teleological role for TNFa in the heart in systemic sepsis remains largely speculative at present, one can envision at least two separate portfolios of beneficial biological responses that might be induced by TNFa: the first set of responses would delimit the spread of microorganisms within the myocardium by upregulating the expression of cell adhesion molecules for neutrophils and monocytes as well as facilitating the generation of free radicals by these cell types (49, 50) ; the second set of responses would protect the cardiac myocyte against oxidative or hemodynamic stress by upregulating the expression of heat shock proteins or the expression of manganese superoxide dismutase, by increasing regional myocardial blood flow through the local generation of nitric oxide, and/ or by protecting the cardiac myocyte against hypoxic injury (51-53). Thus, we postulate that when TNFa is elaborated in low concentrations in the setting of systemic sepsis, it may serve to protect the myocardium; however, when TNFa is elaborated in the heart at relatively higher concentrations, the protective role of TNFa may still occur, albeit at the expense of a profound but fully reversible (3, 13) depression of myocardial function.
